EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study)
| dc.contributor.author | Lam, Thomas B L | |
| dc.contributor.author | MacLennan, Steven | |
| dc.contributor.author | Willemse, Peter-Paul M. | |
| dc.contributor.author | Mason, Malcolm D. | |
| dc.contributor.author | Plass, Karin | |
| dc.contributor.author | Shepherd, Robert | |
| dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-10-02T23:04:42Z | |
| dc.date.available | 2020-10-02T23:04:42Z | |
| dc.date.embargoedUntil | 2020-10-03 | |
| dc.date.issued | 2019-12-01 | |
| dc.description | The authors are grateful to the following individuals and organisations for the following contributions: R. Bryan Rumble, MSc for reviewing and commenting on the manuscript; American Society of Clinical Oncology (ASCO) for providing members who participated in the survey and consensus group meeting; IPSEN for providing an unrestricted educational grant; however IPSEN did not have any access to the study data nor did they have any control over the final manuscript; European Association of Urology (EAU) for providing an unrestricted educational grant; however the EAU did not have any access to the data nor did they have any control over the final manuscript. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 24 | |
| dc.format.extent | 328102 | |
| dc.format.extent | 775970 | |
| dc.identifier | 147241110 | |
| dc.identifier | c4116266-2117-4b66-b11e-9ab4186003d5 | |
| dc.identifier | 85072774547 | |
| dc.identifier | 31587989 | |
| dc.identifier | 000496915900015 | |
| dc.identifier.citation | Lam, T B L, MacLennan, S, Willemse, P-P M, Mason, M D, Plass, K & Shepherd, R 2019, 'EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study)', European Urology, vol. 76, no. 6, pp. 790-813. https://doi.org/10.1016/j.eururo.2019.09.020 | en |
| dc.identifier.doi | 10.1016/j.eururo.2019.09.020 | |
| dc.identifier.iss | 6 | en |
| dc.identifier.issn | 0302-2838 | |
| dc.identifier.other | ORCID: /0000-0002-2691-8421/work/63244102 | |
| dc.identifier.other | Mendeley: 6fdf58bf-a8a4-3e7c-a8db-2b27b4acb928 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15196 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85072774547&partnerID=8YFLogxK | en |
| dc.identifier.vol | 76 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Urology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Deferred treatment with curative intent | en |
| dc.subject | Active surveillance and monitoring | en |
| dc.subject | Localised prostate cancer | en |
| dc.subject | Eligibility | en |
| dc.subject | Follow-up | en |
| dc.subject | Reclassification | en |
| dc.subject | Outcome measures | en |
| dc.subject | Consensus statements | en |
| dc.subject | Delphi survey | en |
| dc.subject | Consensus group meeting | en |
| dc.subject | Clinical practice guidelines | en |
| dc.subject | R Medicine | en |
| dc.subject | Urology | en |
| dc.subject.lcc | R | en |
| dc.title | EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study) | en |
| dc.type | Journal article | en |
